Tag: tumor models market trends

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Tumor Models Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The tumor models market has observed rapid expansion in recent years. Its valuation is anticipated to grow from $2.13 billion in 2025 to $2.37 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.3%. The historical increase can be attributed to elements like the constrained access to advanced tumor models, a reliance on traditional 2D cell cultures, augmented cancer research funding, a rising prevalence of cancer, and the incorporation of orthotopic and heterotopic models.

The market size for tumor models is projected to experience significant expansion in the coming years. It is forecast to attain a value of $3.57 billion in 2030, with a compound annual growth rate (CAGR) of 10.8%. This projected growth during the forecast period is primarily driven by advancements in organ-on-a-chip and 3D spheroid technologies, a heightened focus on personalized oncology treatments, the expansion of contract research organizations (CROs) engaged in tumor research, increasing expenditure on pharmaceutical R&D, and the integration of AI and big data analytics into tumor model investigations. Prominent trends expected in this period encompass the rising utilization of 3D tumor spheroids and organ-on-a-chip models, an escalating demand for personalized medicine and targeted cancer therapies, the proliferation of xenograft and genetically engineered mouse models (GEMMs), an increase in drug discovery and toxicology studies employing tumor models, and closer collaborations between pharmaceutical companies and academic institutions.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=38746309&type=smp&name=Tumor%20Models%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Tumor Models Market Growth Catalysts And Demand Drivers

The increasing demand for personalized medicine is set to propel the expansion of the tumor models market. Personalized medicine describes a medical framework that customizes treatments and healthcare for individuals based on their genetic and lifestyle information. This rise in personalized medicine is attributed to individuals favoring health technologies that provide real-time monitoring and treatment plans specifically adapted to their unique biology. Tumor models aid personalized medicine by acting as experimental platforms that replicate the behavior of actual human cancers, allowing researchers and clinicians to test and forecast how individual patients’ tumors will react to specific treatments, thereby facilitating a more customized therapeutic approach. As an illustration, in February 2024, the US-based nonprofit organization, Personalized Medicine Coalition (PMC), reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a considerable increase from the 12 approved in 2022. Thus, the growing demand for personalized medicine is directly driving the growth of the tumor models market.

Tumor Models Market Segment Landscape: Which Areas Lead Development?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Tumor Models Market Trends Shaping Long-Term Demand

Leading companies in the tumor models market are prioritizing the development of advanced solutions, such as tumor spheroid models, to boost the physiological relevance and predictive accuracy of in vitro cancer models. Tumor spheroid models are defined as three-dimensional (3D) aggregates of cancer cells that spontaneously form spherical structures when grown in culture. For instance, in June 2024, Predictive Oncology, a US-based provider of advanced 3D cell culture technologies and predictive oncology solutions, launched new 3D cell technology to accelerate the discovery of cancer therapeutic drugs. This technology offers unique features, including advanced 3D tumor spheroid and organoid models that closely mimic the tumor microenvironment, high-throughput screening capabilities for rapid drug testing, support for patient-derived personalized tumor models, detailed analysis of drug penetration in 3D structures, and integration with AI-driven data analytics for enhanced predictive accuracy and deeper insights into therapeutic responses.

Tumor Models Market Industry Leaders And Competitive Landscape

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

View The Full Tumor Models Market Report:

https://thebusinessresearchcompany.com/report/tumor-models-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Tumor Models Market Regional Breakdown: Where Is Demand Concentrated?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Tumor Models Market CAGR Analysis And Future Market Development

The tumor models market has experienced rapid expansion over recent years, with its value rising from $2.13 billion in 2025 to an estimated $2.37 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.3%. This historic growth is driven by several key factors, including the restricted availability of advanced tumor models, a continued dependence on conventional 2D cell cultures, a surge in funding for cancer research, the escalating incidence of cancer, and the increased adoption of both orthotopic and heterotopic models.

The tumor models market is projected to experience rapid expansion in the coming years, reaching $3.57 billion by 2030 with a compound annual growth rate (CAGR) of 10.8%. This forecasted growth is driven by progress in organ-on-a-chip and 3D spheroid technologies, a heightened focus on personalized oncology treatments, the growing role of contract research organizations (CROs) in tumor research, rising pharmaceutical R&D spending, and the incorporation of AI and big data analytics into tumor model studies. Key trends shaping this period include the growing adoption of 3D tumor spheroids and organ-on-a-chip platforms, an increased demand for personalized medicine and targeted cancer therapies, the expanded use of xenograft and genetically engineered mouse models (GEMMs), the advancement of drug discovery and toxicology investigations utilizing tumor models, and collaborations between pharmaceutical firms and academic institutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Tumor Models Market Growth Drivers: What Factors Are Accelerating Expansion?

The rising need for tailored therapeutic approaches is anticipated to advance the tumor models market in the coming years. Personalized medicine is defined as a healthcare model that leverages genetic information and lifestyle factors to customize treatments and medical care for individual patients. Its increasing prevalence stems from a growing preference for health technologies capable of real-time monitoring and the development of treatment plans aligned with a person’s unique biological profile. Tumor models facilitate personalized medicine by serving as experimental platforms that replicate the behavior of actual human cancers, allowing researchers and clinicians to evaluate and predict how a specific patient’s tumor might react to various therapies, thus fostering a more targeted treatment strategy. For example, in February 2024, the Personalized Medicine Coalition (PMC), a non-profit organization based in the United States, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a marked rise compared to the 12 approvals recorded in 2022. Consequently, the escalating demand for personalized medicine is fueling expansion in the tumor models market.

Tumor Models Market Segment Outlook: Which Categories Are Expanding The Fastest?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Tumor Models Market Trends: What Is Shaping Future Industry Growth?

Key players in the tumor models market are prioritizing the creation of cutting-edge solutions like tumor spheroid models to improve how accurately in vitro cancer models mirror real physiological conditions and predict therapeutic outcomes. These spheroid models are three-dimensional clusters of cancer cells that naturally form spherical aggregates during culture. In a notable example from June 2024, Predictive Oncology, a company headquartered in the United States that specializes in advanced 3D cell culture techniques and predictive oncology tools, introduced a novel 3D cell technology aimed at accelerating the discovery of cancer drugs. This technology stands out for several distinctive attributes, including sophisticated 3D tumor spheroid and organoid models that effectively replicate the tumor microenvironment, high-throughput screening capabilities that enable rapid drug evaluation, support for constructing personalized tumor models derived directly from patients, in-depth analysis of how drugs penetrate 3D structures, and seamless integration with AI-driven data analytics to boost predictive accuracy and provide richer insights into treatment responses.

Tumor Models Market Key Companies And Competitive Benchmarking

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Access The Complete Tumor Models Market Report:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Tumor Models Market Regional Analysis: Which Region Leads By Revenue?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Tumor Models Market?

The tumor models market has seen significant expansion recently. It will grow from $2.13 billion in 2025 to $2.37 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. This historical expansion can be linked to factors such as the restricted access to sophisticated tumor models, a dependence on conventional 2D cell cultures, a rise in funding for cancer research, the increasing incidence of cancer, and the implementation of orthotopic and heterotopic models.

The tumor models market is anticipated to experience substantial expansion over the next few years. It is projected to reach **$3.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%**. This growth during the forecast period is primarily driven by advancements in organ-on-a-chip and 3D spheroid technologies, a heightened focus on personalized oncology treatments, the expansion of contract research organizations (CROs) in tumor research, increasing pharmaceutical R&D expenditure, and the integration of AI and big data analytics in tumor model studies. Prominent trends expected in this period include the increasing use of 3D tumor spheroids and organ-on-a-chip models, a rising demand for personalized medicine and targeted cancer therapies, the expansion of xenograft and genetically engineered mouse models (GEMMs), growth in drug discovery and toxicology studies utilizing tumor models, and strengthened collaboration between pharmaceutical companies and academic institutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Which Major Factors Are Contributing To The Development Of The Tumor Models Market?

The increasing need for personalized medicine is anticipated to drive expansion within the tumor models market. This medical approach involves utilizing genetic and lifestyle data to customize healthcare and treatments for individual requirements. Its increasing prevalence stems from individuals favoring health technologies that provide real-time monitoring and treatment regimens tailored to their distinct biological profiles. Tumor models support personalized medicine by serving as experimental platforms that replicate human cancer behavior, enabling researchers and clinicians to forecast how individual patient tumors will react to specific therapies, thus facilitating a more customized therapeutic strategy. For example, data from February 2024 by the U.S.-based nonprofit, Personalized Medicine Coalition (PMC), indicates that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable rise from the 12 approved in 2022. Consequently, the escalating demand for personalized medicine is fueling the expansion of the tumor models market.

How Is The Tumor Models Market Distributed Across Key Segments?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Which Trends Are Shaping The Tumor Models Market Landscape?

Leading companies in the tumor models market are concentrating on creating sophisticated solutions, particularly tumor spheroid models, to improve the physiological relevance and predictive precision of in vitro cancer models. Tumor spheroid models are characterized as three-dimensional (3D) clusters of cancer cells that naturally organize into spherical structures within a culture environment. For example, in June 2024, Predictive Oncology, a US-based company providing advanced 3D cell culture technologies and predictive oncology solutions, introduced new 3D cell technology designed to accelerate the discovery of cancer therapeutic drugs. This technology features several unique aspects, including advanced 3D tumor spheroid and organoid models that closely simulate the tumor microenvironment, high-throughput screening capabilities for rapid drug assessment, support for patient-derived personalized tumor models, comprehensive analysis of drug penetration within 3D structures, and integration with AI-driven data analytics to boost predictive accuracy and offer deeper insights into therapeutic responses.

Who Are The Major Companies Operating In The Tumor Models Market?

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Access The Complete Tumor Models Market Report:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Which Region Contributes The Most To The Tumor Models Market?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Tumor Models Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2026, By The Business Research Company

Voice Payment Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Tumor Models Market From 2026 To 2030?

The tumor models market has experienced substantial expansion in its size over recent years. Forecasts indicate its value will ascend from $2.13 billion in 2025 to $2.37 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.3%. The growth observed during the historic period stems from factors such as limited availability of advanced tumor models, reliance on traditional 2d cell cultures, growing cancer research funding, increasing prevalence of cancer, and the adoption of orthotopic and heterotopic models.

The tumor models market is poised for substantial growth over the next few years, with projections indicating it will reach $3.57 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.8%. This anticipated expansion can be attributed to advancements in organ-on-a-chip and 3D spheroid technologies, an increasing focus on personalized oncology treatments, the expansion of contract research organizations (CROs) in tumor research, rising pharmaceutical R&D expenditure, and the integration of AI and big data analytics in tumor model studies. Major trends during this period include the increasing use of 3D tumor spheroids and organ-on-a-chip models, a rising demand for personalized medicine and targeted cancer therapies, the expansion of xenograft and genetically engineered mouse models (GEMMs), growth in drug discovery and toxicology studies utilizing tumor models, and increased collaboration between pharmaceutical companies and academic institutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

What Leading Drivers Are Supporting The Tumor Models Market Expansion?

The increasing need for personalized medical approaches is projected to fuel the expansion of the tumor models market in the future. This medical approach, known as personalized medicine, involves utilizing details about an individual’s genetic makeup and environmental factors to customize treatments and health services according to their unique requirements. The growing popularity of personalized medicine stems from individuals favoring health technologies that provide real-time monitoring and therapeutic strategies tailored to their distinct biological profiles. Tumor models assist personalized medicine by serving as experimental platforms that imitate the characteristics of actual human cancers, thereby enabling researchers and clinicians to assess and forecast how tumors from individual patients will react to particular therapies, leading to a more customized treatment strategy. As an example, in February 2024, data from the Personalized Medicine Coalition (PMC), a U.S. based nonprofit entity, indicated that the U.S. Food and Drug Administration (FDA) granted approval to 26 novel personalized medicines in 2023, marking a notable rise from the 12 approvals in 2022. Consequently, the escalating demand for personalized medicine is a key impetus for the expansion of the tumor models market.

How Is The Tumor Models Market Organized By Segment Classification?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

What Trends Are Affecting The Direction Of The Tumor Models Market?

Leading companies in the tumor models market are concentrating on developing advanced solutions, such as tumor spheroid models, to improve the physiological relevance and predictive accuracy of in vitro cancer models. Tumor spheroid models are characterized as three-dimensional (3D) aggregates of cancer cells that spontaneously form spherical structures in culture. For example, in June 2024, Predictive Oncology, a US-based provider of advanced 3D cell culture technologies and predictive oncology solutions, introduced novel 3D cell technology designed to accelerate cancer therapeutic drug discovery. This technology offers unique features, including advanced 3D tumor spheroid and organoid models that closely replicate the tumor microenvironment, high-throughput screening capabilities for rapid drug testing, support for patient-derived personalized tumor models, detailed analysis of drug penetration in 3D structures, and integration with AI-driven data analytics for enhanced predictive accuracy and deeper insights into therapeutic responses.

Who Are The Industry Participants Involved In The Tumor Models Market?

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Get The Full Tumor Models Market Report:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Which Region Accounts For The Largest Portion Of The Tumor Models Market?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Tumor Models Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Browse Through More Reports Similar to the Global Tumor Models Market 2026, By The Business Research Company

Voice Payment Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Tumor Models Market From 2026 To 2030?

The tumor models market has observed rapid expansion in recent years. It is anticipated to grow from $2.13 billion in 2025 to $2.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.3%. The historical increase in this market was influenced by factors such as the limited availability of advanced tumor models, the reliance on traditional 2D cell cultures, growing cancer research funding, the increasing prevalence of cancer, and the adoption of orthotopic and heterotopic models.

The tumor models market is anticipated to experience significant expansion in the coming years, with its size projected to reach $3.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.8%. This growth throughout the forecast period is largely attributable to advancements in organ-on-a-chip and 3D spheroid technologies, an increasing focus on personalized oncology treatments, the expansion of contract research organizations (CROs) involved in tumor research, rising pharmaceutical R&D expenditure, and the integration of AI and big data analytics into tumor model studies. Major trends for the forecast period include the increasing use of 3D tumor spheroids and organ-on-a-chip models, a growing demand for personalized medicine and targeted cancer therapies, the broadening application of xenograft and genetically engineered mouse models (GEMMs), an increase in drug discovery and toxicology studies leveraging tumor models, and enhanced collaboration between pharmaceutical companies and academic institutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

What Key Drivers Are Influencing The Growth Of The Tumor Models Market?

The increasing need for personalized medicine is anticipated to drive expansion in the tumor models market in the future. Personalized medicine is defined as a healthcare approach that leverages an individual’s genetic and lifestyle data to customize treatments and medical care according to their unique requirements. The growth of personalized medicine stems from a consumer preference for health technologies that provide real-time monitoring and treatment strategies tailored to individual biological profiles. Tumor models support personalized medicine by serving as experimental platforms that replicate the behavior of human cancers, enabling researchers and clinicians to assess and forecast how specific treatments will affect individual patients’ tumors, thereby facilitating a more customized therapeutic strategy. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, marking a notable rise from the 12 approved in 2022. Consequently, the expanding demand for personalized medicine is fueling the development of the tumor models market.

Which Segments Are Included In The Analysis Of The Tumor Models Market?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Which Trends Are Impacting The Growth Of The Tumor Models Market?

Leading companies in the tumor models market are concentrating on developing sophisticated solutions, such as tumor spheroid models, to enhance the physiological relevance and predictive accuracy of in vitro cancer models. These tumor spheroid models are three-dimensional (3D) aggregates of cancer cells that spontaneously form spherical structures in culture. For example, in June 2024, Predictive Oncology, a US-based provider of advanced 3D cell culture technologies and predictive oncology solutions, introduced novel 3D cell technology to accelerate cancer therapeutic drug discovery. This technology offers distinct features, including advanced 3D tumor spheroid and organoid models that closely mimic the tumor microenvironment, high-throughput screening capabilities for rapid drug testing, support for patient-derived personalized tumor models, detailed analysis of drug penetration in 3D structures, and integration with AI-driven data analytics for improved predictive accuracy and deeper insights into therapeutic responses.

Which Key Industry Participants Are Active In The Tumor Models Market?

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Read the full tumor models market report here:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Tumor Models Market?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Tumor Models Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2026, By The Business Research Company

Voice Payment Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the tumor models market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Tumor Models Market show for the 2026–2030 period?

The tumor models market has seen rapid expansion in recent years. It is projected to increase from $2.13 billion in 2025 to $2.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.3%. Historically, this growth can be ascribed to factors such as the limited availability of advanced tumor models, the reliance on traditional 2D cell cultures, growing cancer research funding, the increasing prevalence of cancer, and the adoption of orthotopic and heterotopic models.

The tumor models market is anticipated to experience significant expansion in the coming years. This market is projected to reach $3.57 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.8%. Several factors contribute to this growth during the forecast period, including advancements in organ-on-a-chip and 3D spheroid technologies, a heightened emphasis on personalized oncology treatments, the expanding role of contract research organizations (CROs) in tumor research, increased pharmaceutical R&D spending, and the incorporation of AI and big data analytics into tumor model investigations. Key trends anticipated during this period involve a greater adoption of 3D tumor spheroids and organ-on-a-chip models, an escalating need for personalized medicine and targeted cancer therapies, the broadening application of xenograft and genetically engineered mouse models (GEMMs), an increase in drug discovery and toxicology studies employing tumor models, and enhanced collaborations between pharmaceutical firms and academic bodies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

What Drivers Are Shaping The Development Of The Tumor Models Market?

The increasing need for customized medicine is anticipated to fuel the expansion of the tumor models market in the future. Customized medicine describes a healthcare approach that leverages details regarding an individual’s genetic makeup and daily habits to develop treatments and care plans uniquely suited to them. The emergence of personalized medicine stems from individuals favoring health solutions that provide real-time surveillance and therapeutic strategies tailored to their distinct biological profiles. Tumor models assist personalized medicine by serving as experimental platforms that replicate the characteristics of actual human cancers, thereby enabling scientists and doctors to evaluate and forecast the response of individual patient tumors to particular therapies, facilitating a more customized therapeutic strategy. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, which marked a considerable rise from the 12 approved in 2022. Consequently, the escalating requirement for personalized medicine is propelling the development of the tumor models market.

Which Segments Are Contributing To The Growth Of The Tumor Models Market?

The tumor models market covered in this report is segmented –

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

What Trends Are Expected To Impact The Competitive Landscape Of The Tumor Models Market?

Leading companies in the tumor models market are prioritizing the creation of advanced solutions, such as tumor spheroid models, to improve the physiological relevance and forecasting accuracy of in vitro cancer models. Tumor spheroid models are characterized as three-dimensional (3D) clusters of cancer cells that naturally develop into spherical configurations in culture. As an example, in June 2024, Predictive Oncology, a US-based provider of sophisticated 3D cell culture technologies and predictive oncology solutions, unveiled new 3D cell technology to speed up the discovery of cancer therapeutic drugs. This technology features unique capabilities including advanced 3D tumor spheroid and organoid models that closely simulate the tumor microenvironment, high-throughput screening for quick drug assessment, support for patient-derived personalized tumor models, comprehensive analysis of drug penetration in 3D structures, and integration with AI-driven data analytics to enhance predictive accuracy and provide deeper insights into therapeutic responses.

Who Are The Major Companies Operating In The Tumor Models Market?

Major companies operating in the tumor models market are WuXi AppTec Co Ltd., Charles River Laboratories International Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Tumor Models Market?

North America was the largest region in the tumor models market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Tumor Models Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2026, By The Business Research Company

Voice Payment Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Market Report 2026

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the tumor models market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Tumor Models Market?

The tumor model market has seen swift expansion over recent years. It is forecast to increase from $1.92 billion in 2024 to $2.13 billion in 2025, at a compound annual growth rate (CAGR) of 11.3%. This historical growth can be linked to factors such as a rise in cancer cases, increasing requests for personalized medicine, a greater requirement for enhanced preclinical predictability, the growing application of patient-derived xenograft models, and an expanding reliance on in vivo efficacy data.

The tumor model market size is projected for substantial growth in the coming years. It is expected to expand to $3.23 billion by 2029, at a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period can be attributed to an increasing focus on human-relevant models, a rising demand for precision oncology, the proliferation of immuno-oncology, a growing need for high-throughput screening models, and an expanding interest in rare cancer models. Significant trends for the forecast period include the evolution of three-dimensional (3D) cell culture models, advancements in pharmaceutical research and developments, progress in cell culture technology, the integration of AI in cancer modelling, and the development of patient-derived organoids.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Which Industry Forces Are Driving The Tumor Models Market Forward?

The expansion of the tumor models market is anticipated to be driven by the increasing need for personalized medicine. This approach, personalized medicine, involves utilizing an individual’s genetic and lifestyle data to customize treatments and healthcare services according to their unique requirements. Its increasing prominence stems from individuals’ preference for health technologies that provide real-time monitoring and therapeutic strategies specifically adapted to their distinct biological makeup. Tumor models support personalized medicine by serving as experimental platforms that replicate the behavior of actual human cancers, thereby enabling researchers and clinicians to test and forecast how tumors from individual patients will react to particular treatments, leading to a more customized therapeutic strategy. As an illustration, the Personalized Medicine Coalition, a US-based professional membership organization, reported in February 2023 that in 2022, the authorization of 12 novel personalized medicines constituted roughly 34% of all newly approved therapies, marking a significant rise compared to prior years. Consequently, the escalating demand for personalized medicine is propelling the expansion of the tumor models market.

How Is The Tumor Models Market Organized By Different Segments?

The tumor models market covered in this report is segmented

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

What Current And Upcoming Trends Are Shaping The Tumor Models Market?

Leading companies in the tumor models market are prioritizing the development of sophisticated solutions, particularly tumor spheroid models, to boost the physiological relevance and predictive accuracy of in vitro cancer studies. Tumor spheroid models are defined as three-dimensional (3D) collections of cancer cells that spontaneously create spherical formations in culture. For example, in June 2024, Predictive Oncology, a US-based company providing advanced 3D cell culture technologies and predictive oncology solutions, unveiled a new 3D cell technology to expedite cancer therapeutic drug discovery. This technology incorporates distinctive features such as advanced 3D tumor spheroid and organoid models that closely emulate the tumor microenvironment, high-throughput screening capacities for swift drug testing, provisions for patient-derived personalized tumor models, detailed examination of drug penetration within 3D structures, and seamless integration with AI-driven data analytics to improve predictive accuracy and generate deeper insights into therapeutic responses.

Who Are The Primary Market Leaders In The Tumor Models Market?

Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

How Do Regional Dynamics Influence The Tumor Models Market Performance?

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2025, By The Business Research Company

Voice Payment Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Commerce Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Payments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/payments-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Tumor Models Market By 2029?

The tumor model market has experienced rapid expansion in recent years. This market is projected to expand from $1.92 billion in 2024 to $2.13 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.3%. Historically, this expansion is linked to factors such as a rise in cancer cases, greater demand for personalized medicine, an escalating requirement for improved preclinical predictability, the increasing application of patient-derived xenograft models, and a heightened dependence on in vivo efficacy data.

The tumor model market size is anticipated to experience substantial expansion over the coming years. Its value is projected to reach $3.23 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.9%. This forecasted growth is attributable to an increasing emphasis on human-relevant models, a rising demand for precision oncology, the proliferation of immuno-oncology, a growing need for high-throughput screening models, and a broadening interest in rare cancer models. Key trends for the forecast period include the evolution of three-dimensional (3D) cell culture models, ongoing pharmaceutical research and developments, continuous advancements in cell culture technology, the integration of AI into cancer modelling, and the development of patient-derived organoids.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

Which Drivers Are Impacting The Tumor Models Market?

The expanding need for personalized medicine is projected to stimulate the growth of the tumor models market moving forward. Personalized medicine signifies a healthcare framework that utilizes an individual’s genetic and lifestyle details to customize treatments and care plans to their specific requirements. The emergence of personalized medicine is attributable to individuals favoring health technologies that offer real-time monitoring and treatment strategies uniquely designed for their biology. Tumor models support personalized medicine by functioning as experimental platforms that replicate the behavior of actual human cancers, allowing researchers and clinicians to test and predict how individual patients’ tumors will respond to specific treatments, thus enabling a more tailored therapeutic approach. For instance, in February 2023, as per the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the authorization of 12 new personalized medicines constituted approximately 34% of all newly approved therapies, indicating a significant increase from previous years. Therefore, the escalating demand for personalized medicine is propelling the expansion of the tumor models market.

How Is The Tumor Models Market Segmented?

The tumor models market covered in this report is segmented

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

What Key Innovation Trends Are Fueling Advancements In The Tumor Models Market?

Leading companies in the tumor models market are concentrating on creating sophisticated solutions, like tumor spheroid models, to improve the physiological similarity and forecasting precision of in vitro cancer models. Tumor spheroid models are defined as three-dimensional (3D) clusters of cancer cells that naturally develop into spherical shapes within a culture environment. An illustration of this trend occurred in June 2024, when Predictive Oncology, a US-based firm specializing in advanced 3D cell culture technologies and predictive oncology solutions, introduced new 3D cell technology aimed at speeding up the discovery of cancer therapeutic drugs. This technology provides distinct functionalities including advanced 3D tumor spheroid and organoid models that closely imitate the tumor microenvironment, high-throughput screening capacities for swift drug evaluations, assistance for patient-specific personalized tumor models, thorough examination of drug entry into 3D structures, and incorporation with AI-powered data analytics for improved predictive accuracy and more profound understanding of therapeutic reactions.

Which Major Industry Participants Are Leading The Tumor Models Market Growth?

Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

How Is Tumor Models Market Demand Varying Across Different Regions?

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Tumor Models Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

Browse Through More Reports Similar to the Global Tumor Models Market 2025, By The Business Research Company

Voice Payment Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-payment-software-global-market-report

Voice Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-banking-global-market-report

Voice Commerce Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/voice-commerce-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Tumor Models Market Evolve in Terms of Growth and Size by 2029?

The size of the tumor model market has experienced swift expansion in recent years. The market, which was valued at $1.92 billion in 2024, is projected to increase to $2.13 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.3%. This growth during the historic period is driven by factors such as the rise in cancer cases, increased demand for tailor-made medicine, the need for improved preclinical predictability, the growing utilisation of patient-derived xenograft models, and a greater dependence on in vivo efficacy data.

In the coming years, the tumor model market is anticipated to witness a quick expansion. By 2029, it’s predicted to reach a value of $3.23 billion, with a compound annual growth rate (CAGR) of 10.9%. Factors contributing to this growth during the forecast period include the increasing emphasis on models relevant to humans, heightened demand for precision oncology, the emergence of immuno-oncology, and the rising need for high-throughput screening models. There is also a growing interest in rare cancer models. Significant trends projected during this period involve advancements such as three-dimensional (3D) cell culture models, progress in pharmaceutical research, improvements in cell-culture technology, the incorporation of artificial intelligence in cancer modelling, and the introduction of patient-derived organoids.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27441&type=smp

What factors are expected to fuel Tumor Models market growth in the coming years?

The tumor models market is projected to expand due to the increasing demand for personalized medicine. Personalized medicine is characterized by tailor-made healthcare and treatments, taking into account the individual’s genes and lifestyle. This personalized approach is on the rise as people are inclined towards health technologies offering real-time monitoring and bespoke treatment plans suiting their distinct biology. Tumor models contribute to personalized medicine by providing a platform for researchers and clinicians to determine how a person’s tumor will respond to certain treatments. These models replicate the characteristics of real human cancers, facilitating a more patient-specific therapeutic approach. In line with this, the Personalized Medicine Coalition, a professional membership organization based in the US, reported in February 2023 that in 2022, 12 new personalized medicines, making up around 34% of all newly approved therapies, were given the green light. This signifies a significant hike from preceding years. Consequently, the escalating demand for personalized medicine is stimulating the growth of the tumor models market.

What Are The Key Findings From The Segmentation Analysis Of The Tumor Models Market?

The tumor models market covered in this report is segmented

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

Which Trends Are Expected To Shape The Future Of The Tumor Models Market?

Prominent businesses in the tumor models market are concentrating their efforts towards innovating advanced solutions like tumor spheroid models, to increase the physiological relevancy and predictive precision of in vitro cancer models. Tumor spheroid models are essentially three-dimensional (3D) accumulations of cancer cells that naturally form spherical structures in culture. For example, in June 2024, Predictive Oncology, a firm based in the US that provides high-end 3D cell culture technologies and predictive oncology solutions, introduced a new 3D cell technology to speed up the discovery of therapeutic treatments for cancer. The technology presents unique features such as cutting-edge 3D tumor spheroid and organoid models that accurately replicate the tumor microenvironment, along with rapid drug testing via high-throughput screening functions. It also facilitates the creation of personalized tumor models derived from patients, performs detailed assessment of drug penetration in 3D structures, and incorporates AI-powered data analytics for improving predictive accuracy and gaining more profound understanding of therapeutic responses.

What Are The Most Active Companies In The Tumor Models Market Today?

Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tumor-models-global-market-report

Which Regional Markets Are Attracting The Most Investment In Tumor Models?

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=27441&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model